Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Gastrointestinal cancer

A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer

Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu

Cancer Res Treat. 2024;56(2):602-615. Published online October 12, 2023 DOI: https://doi.org/10.4143/crt.2023.726

Crossref 1

ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer

Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-kun Lee, Hong Jae Chon

Cancer Res Treat. 2023;55(4):1291-1302. Published online May 3, 2023 DOI: https://doi.org/10.4143/crt.2022.1450

Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer

Jihoon Kang, Ji-Young Lee, Sunmin Lee, Danbee Kim, Jinyeong Lim, Ha Ra Jun, Seyeon Jeon, Young-Ae Kim, Hye Seon Park, Kyu-pyo Kim, Sung-Min Chun, Hee Jin Lee, Changhoon Yoo

Cancer Res Treat. 2023;55(1):219-230. Published online April 6, 2022 DOI: https://doi.org/10.4143/crt.2021.1166

Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer

Hye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh

Cancer Res Treat. 2022;54(2):541-553. Published online August 6, 2021 DOI: https://doi.org/10.4143/crt.2021.473

Web of Science 4 Crossref 5

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection

Lejia Sun, Yuxi Wei, Yang Chen, Wenmo Hu, Xin Ji, Haifeng Xu, Shunda Du, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Huayu Yang, Yilei Mao

Cancer Res Treat. 2021;53(2):528-540. Published online November 23, 2020 DOI: https://doi.org/10.4143/crt.2020.833

Web of Science 4 Crossref 3

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer

Jeesun Yoon, Seo Young Kang, Kyung-Hun Lee, Gi Jeong Cheon, Do-Youn Oh

Cancer Res Treat. 2021;53(2):471-479. Published online October 22, 2020 DOI: https://doi.org/10.4143/crt.2020.577

Web of Science 2 Crossref 2

Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3^- CD4⁺ T Cells in Biliary Tract Cancer

Hyung-Don Kim, Jwa Hoon Kim, Yeon-Mi Ryu, Danbee Kim, Sunmin Lee, Jaehoon Shin, Seung-Mo Hong, Ki-Hun Kim, Dong‐Hwan Jung, Gi‐Won Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Baek-Yeol Ryoo, Jae Ho Jeong, Kyu-pyo Kim, Sang-Yeob Kim, Changhoon Yoo

Cancer Res Treat. 2021;53(1):162-171. Published online August 31, 2020 DOI: https://doi.org/10.4143/crt.2020.704

Web of Science 8 Crossref 7

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

Ah-Rong Nam, Mei-Hua Jin, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Do-Youn Oh, Yung-Jue Bang

Cancer Res Treat. 2020;52(3):945-956. Published online April 17, 2020 DOI: https://doi.org/10.4143/crt.2020.080

Web of Science 14 Crossref 14

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer

Ah-Rong Nam, Mei Hua Jin, Ji Eun Park, Ju-Hee Bang, Do-Youn Oh, Yung-Jue Bang

Cancer Res Treat. 2019;51(3):1167-1179. Published online December 3, 2018 DOI: https://doi.org/10.4143/crt.2018.526

Web of Science 20 Crossref 20

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin

Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo

Cancer Res Treat. 2019;51(3):901-909. Published online October 4, 2018 DOI: https://doi.org/10.4143/crt.2018.326

Web of Science 15 Crossref 16

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer

Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Bang

Cancer Res Treat. 2019;51(3):886-900. Published online October 1, 2018 DOI: https://doi.org/10.4143/crt.2018.375

Web of Science 5 Crossref 3

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer

Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang

Cancer Res Treat. 2018;50(4):1324-1330. Published online January 8, 2018 DOI: https://doi.org/10.4143/crt.2017.526

Web of Science 19 Crossref 19

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis

Jun Ho Ji, Young Saing Kim, Inkeun Park, Soon Il Lee, Rock Bum Kim, Joon Oh Park, Sung Yong Oh, In Gyu Hwang, Joung-Soon Jang, Haa-Na Song, Jung-Hun Kang

Cancer Res Treat. 2018;50(3):791-800. Published online August 23, 2017 DOI: https://doi.org/10.4143/crt.2017.044

Web of Science 7 Crossref 6

Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer

Hyung Soon Park, Ji Soo Park, You Jin Chun, Yun Ho Roh, Jieun Moon, Hong Jae Chon, Hye Jin Choi, Joon Seong Park, Dong Ki Lee, Se-Joon Lee, Dong Sup Yoon, Hei-Cheul Jeung

Cancer Res Treat. 2017;49(4):1127-1139. Published online February 6, 2017 DOI: https://doi.org/10.4143/crt.2016.538

Web of Science 16 Crossref 17

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang

Cancer Res Treat. 2017;49(3):807-815. Published online January 18, 2017 DOI: https://doi.org/10.4143/crt.2016.326

Web of Science 6 Crossref 6

Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients

Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park

Cancer Res Treat. 2016;48(2):583-595. Published online July 22, 2015 DOI: https://doi.org/10.4143/crt.2015.091

Web of Science 38 Crossref 34

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim

Cancer Res Treat. 2015;47(3):343-361. Published online May 18, 2015 DOI: https://doi.org/10.4143/crt.2014.308

Web of Science 68 Crossref 64

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

Jieun Lee, Tae Ho Hong, In Seok Lee, Young Kyoung You, Myung Ah Lee

Cancer Res Treat. 2015;47(2):259-265. Published online September 12, 2014 DOI: https://doi.org/10.4143/crt.2013.230

Web of Science 11 Crossref 11